22nd Century Group Inc (OQ:XXII)

Sector:  Consumer Non-Cyclicals Industry:  Tobacco
 
See Regulatory Filings on SEC
Company Contact
Address: 8560 Main St Ste 4
WILLIAMSVILLE NY 14221-7435
Tel: 1-214-5978200
Website: https://www.xxiicentury.com
IR: See website
<
Key People
Lawrence D. Firestone
Chairman of the Board, Chief Executive Officer
R. Hugh Kinsman
Chief Financial Officer
Daniel Otto
Chief Financial Officer
Jonathan Staffeldt
General Counsel
   
Business Overview
22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The tobacco segment is engaged in the sale of its reduced nicotine content (RNC) cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. It uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products.
Financial Overview
For the fiscal year ended 31 December 2023, 22nd Century Group Inc revenues decreased 20% to $32.2M. Net loss applicable to common stockholders excluding extraordinary items increased 77% to $64.7M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Interest expense increase from $55K to $9.4M (expense).
Employees: 64 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $21.97M as of Dec 31, 2023
Annual revenue (TTM): $32.20M as of Dec 31, 2023
EBITDA (TTM): -$38.32M as of Dec 31, 2023
Net annual income (TTM): -$64.68M as of Dec 31, 2023
Free cash flow (TTM): -$60.60M as of Dec 31, 2023
Net Debt Last Fiscal Year: $12.39M as of Dec 31, 2023
Shares outstanding: 5,603,278 as of Apr 8, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.